104 related articles for article (PubMed ID: 15879633)
1. Cut-off levels based on deviation from standard negative control is better than moderate level based on fixed cut-off for ACA assessed using ELISA for the diagnosis of antiphospholipid syndrome.
Effendy S; Tambunan KL; Reksodiputro AH
Acta Med Indones; 2005; 37(1):12-9. PubMed ID: 15879633
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
Persijn L; Decavele AS; Schouwers S; Devreese K
Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
[TBL] [Abstract][Full Text] [Related]
3. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies.
Fontaine M; Homburger HA; Nichols WL
Thromb Haemost; 2001 Oct; 86(4):1123-4. PubMed ID: 11686339
[No Abstract] [Full Text] [Related]
4. Evaluation of new commercial enzyme-linked immunosorbent assay kits in the laboratory diagnosis of antiphospholipid syndrome in view of the revised classification criteria of the antiphospholipid syndrome.
Devreese KM
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):651-9. PubMed ID: 17102652
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
[TBL] [Abstract][Full Text] [Related]
7. A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests.
Budd R; Harley E; Quarshie A; Henderson V; Harris EN; Pierangeli SS
J Thromb Haemost; 2006 Oct; 4(10):2210-4. PubMed ID: 16856974
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations.
Cavazzana A; Pengo V; Tonello M; Noventa F; Grossi C; Borghi MO; de Moerloose P; Reber G; Ruffatti A
Thromb Haemost; 2009 Apr; 101(4):789-91. PubMed ID: 19350132
[No Abstract] [Full Text] [Related]
11. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose).
Reber G; Arvieux J; Comby E; Degenne D; de Moerloose P; Sanmarco M; Potron G
Thromb Haemost; 1995 Mar; 73(3):444-52. PubMed ID: 7667827
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between anticardiolipin antibodies and fetal intrauterine growth retardation].
Wu J; Zeng W; Chen Z; Lu Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):62-4. PubMed ID: 11938744
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
14. Study of anticardiolipin antibodies in repeated abortions--an institutional experience.
Sheth JJ; Sheth FJ
Indian J Pathol Microbiol; 2001 Apr; 44(2):117-21. PubMed ID: 11883124
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
16. Solid Phase Immunoassay for the Detection of Anticardiolipin Antibodies.
Willis R; Papalardo E; Nigel Harris E
Methods Mol Biol; 2017; 1646():185-199. PubMed ID: 28804830
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
18. Clinical laboratory testing for the antiphospholipid syndrome.
Pierangeli SS; Harris EN
Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301
[TBL] [Abstract][Full Text] [Related]
19. Correction for age of anticardiolipin antibodies cut-off points.
Rapizzi E; Ruffatti A; Tonello M; Piccoli A; Calligaro A; Sfriso P; Todesco S
J Clin Lab Anal; 2000; 14(3):87-90. PubMed ID: 10797605
[TBL] [Abstract][Full Text] [Related]
20. [Anticardiolipin antibodies and primary antiphospholipid syndrome of the central nervous system: report of 10 clinical cases].
Córdova JL; Neira O; Abumohor P; Palma S; Vergara F; Guzmán L
Rev Med Chil; 1991 Jul; 119(7):765-71. PubMed ID: 1844751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
